Concurrent XRD-0394 With Radiation Therapy for High Grade Gliomas

Clinical trial NCT06829173 · RECRUITING

Trial details

NCT number: NCT06829173
Sponsor: NYU Langone Health
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

High-Grade Glioma

Start date: 2025-11-05
Primary completion: 2027-05-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.